Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7268)
All Articles published online
|
Publishing Process of This Article
|
Feb 10, 2014 (publication date) through Jul 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu W, Zhou L, Qian JQ, Qiu TZ, Shu YQ, Liu P. Temozolomide for treatment of brain metastases: A review of 21 clinical trials. World J Clin Oncol 2014; 5(1): 19-27 [PMID: 24527399 DOI: 10.5306/wjco.v5.i1.19] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i1/19.htm |
| Number | Citing Articles |
| 1 |
Oihane Erice, Michael P. Smith, Rachel White, Ibai Goicoechea, Jorge Barriuso, Chris Jones, Geoffrey P. Margison, Juan C. Acosta, Claudia Wellbrock, Imanol Arozarena. MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide. Molecular Cancer Therapeutics 2015; 14(5): 1236 doi: 10.1158/1535-7163.MCT-14-0810
|
| 2 |
Maria Goldberg, Michel G. Mondragon-Soto, Ghaith Altawalbeh, Lea Baumgart, Jens Gempt, Denise Bernhardt, Stephanie E. Combs, Bernhard Meyer, Amir Kaywan Aftahy. Enhancing outcomes: neurosurgical resection in brain metastasis patients with poor Karnofsky performance score - a comprehensive survival analysis. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1343500
|
| 3 |
Nida Syed, Amber Ilyas, Basir Syed, Aftab Ahmed, Shamshad Zarina, Zehra Hashim. Novel Synergistic Combination of Pamidronate and Temozolomide for
Breast Cancer Therapeutics. Current Cancer Drug Targets 2023; 23(3): 222 doi: 10.2174/1568009622666220921103201
|
| 4 |
Adam Lauko, Bicky Thapa, Mayur Sharma, Baha’eddin Muhsen, Addison Barnett, Yasmeen Rauf, Hamid Borghei-Razavi, Vineeth Tatineni, Pradnya Patil, Alireza Mohammadi, Samuel Chao, Erin S. Murphy, Lilyana Angelov, John Suh, Gene H. Barnett, Amy S. Nowacki, Nathan Pennell, Manmeet S. Ahluwalia. Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85328-w
|
| 5 |
Anastasia V. Suhovskih, Olga P. Molodykh, Victor S. Ushakov, Maxim O. Politko, Dmitry K. Sokolov, Elena V. Koldysheva, Elvira V. Grigorieva. Long-Term Exposure to Temozolomide Affects Locomotor Activity and Cartilage Structure of Elderly Experimental Rats. Biomedicines 2020; 8(12): 541 doi: 10.3390/biomedicines8120541
|
| 6 |
Chandan Kanta Das, Mahitosh Mandal, Donat Kögel. Pro-survival autophagy and cancer cell resistance to therapy. Cancer and Metastasis Reviews 2018; 37(4): 749 doi: 10.1007/s10555-018-9727-z
|
| 7 |
Jing Liu, Bo Jin, Hang Su, Xiujuan Qu, Yunpeng Liu. Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5915-7
|
| 8 |
M. Vesel, J. Rapp, D. Feller, E. Kiss, L. Jaromi, M. Meggyes, G. Miskei, B. Duga, G. Smuk, T. Laszlo, I. Karner, J.E. Pongracz. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. Respiratory Research 2017; 18(1) doi: 10.1186/s12931-017-0537-6
|
| 9 |
Sang-Soo Kim, Antonina Rait, Eric Kim, James DeMarco, Kathleen F. Pirollo, Esther H. Chang. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma. Cancer Letters 2015; 369(1): 250 doi: 10.1016/j.canlet.2015.08.022
|
| 10 |
Theresa Pesch, Harald Schuhwerk, Philippe Wyrsch, Timo Immel, Wilhelm Dirks, Alexander Bürkle, Thomas Huhn, Sascha Beneke. Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2538-0
|
| 11 |
Jacqueline Dinnes, Daniel Saleh, Julia Newton-Bishop, Seau Tak Cheung, Paul Nathan, Rubeta N Matin, Naomi Chuchu, Susan E Bayliss, Yemisi Takwoingi, Clare Davenport, Kathie Godfrey, Colette O'Sullivan, Jonathan J Deeks, Hywel C Williams. Tests to assist in the staging of cutaneous melanoma: a generic protocol. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD012806
|
| 12 |
Herbert B. Newton, Jose J. Otero. Epilepsy and Brain Tumors. 2015; : 29 doi: 10.1016/B978-0-12-417043-8.00003-1
|
| 13 |
Mateusz Jacek Spałek, Tomasz Mandat. Salvage Treatment for Progressive Brain Metastases in Breast Cancer. Cancers 2022; 14(4): 1096 doi: 10.3390/cancers14041096
|
| 14 |
Herbert B. Newton, Ramya Tadipatri, Ekokobe Fonkem. Handbook of Neuro-Oncology Neuroimaging. 2022; : 25 doi: 10.1016/B978-0-12-822835-7.00018-4
|
| 15 |
Federica Franchino, Roberta Rudà, Riccardo Soffietti. Mechanisms and Therapy for Cancer Metastasis to the Brain. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00161
|
| 16 |
Christopher Dardis, Jared Yeo, Kelly Milton, Lynn S. Ashby, Kris A. Smith, Shwetal Mehta, Emad Youssef, Jenny Eschbacher, Kathy Tucker, Laughlin Dawes, Neil Lambie, Elizabeth Algar, Elizabeth Hovey. Atypical Teratoid Rhabdoid Tumor: Two Case Reports and an Analysis of Adult Cases with Implications for Pathophysiology and Treatment. Frontiers in Neurology 2017; 8 doi: 10.3389/fneur.2017.00247
|
| 17 |
Zhenghao Liu, Bingxi Lei, Meiguang Zheng, Zhongjun Li, Shuaibin Huang, Yuefei Deng. Prognostic factors in patients treated with surgery for brain metastases: A single-center retrospective analysis of 125 patients. International Journal of Surgery 2017; 44: 204 doi: 10.1016/j.ijsu.2017.05.033
|
| 18 |
Russell Maxwell, Tomas Garzon‐Muvdi, Evan J. Lipson, William H. Sharfman, Chetan Bettegowda, Kristin J. Redmond, Lawrence R. Kleinberg, Xiaobu Ye, Michael Lim. BRAF‐V600 mutational status affects recurrence patterns of melanoma brain metastasis. International Journal of Cancer 2017; 140(12): 2716 doi: 10.1002/ijc.30241
|
| 19 |
Jacqueline Dinnes, Lavinia Ferrante di Ruffano, Yemisi Takwoingi, Seau Tak Cheung, Paul Nathan, Rubeta N Matin, Naomi Chuchu, Sue Ann Chan, Alana Durack, Susan E Bayliss, Abha Gulati, Lopa Patel, Clare Davenport, Kathie Godfrey, Manil Subesinghe, Zoe Traill, Jonathan J Deeks, Hywel C Williams. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma. Cochrane Database of Systematic Reviews 2019; 2019(7) doi: 10.1002/14651858.CD012806.pub2
|
| 20 |
Ram Kishan Nekkanti, Easwer Hariharan Venkat, Gowtham Matham, Akhilesh Gowda G B, Rajalakshmi Poyuran. Atypical teratoid rhabdoid tumour in the third ventricle of a young adult – a rare presentation. British Journal of Neurosurgery 2023; : 1 doi: 10.1080/02688697.2023.2239919
|
| 21 |
Abdolali Amiri, Phuong Uyen Le, Alexandre Moquin, Gayane Machkalyan, Kevin Petrecca, John W. Gillard, Nathan Yoganathan, Dusica Maysinger. Inhibition of carbonic anhydrase IX in glioblastoma multiforme. European Journal of Pharmaceutics and Biopharmaceutics 2016; 109: 81 doi: 10.1016/j.ejpb.2016.09.018
|
| 22 |
Lihong Qin, Mao Huiwen, Jianguo Wang, Yuanyaun Wang, Salman A. Khan, Ying Zhang, Hong Qiu, Longwei Jiang, Lingfeng He, Yan Zhang, Shaochang Jia. A novel polymerase β inhibitor from phage displayed peptide library augments the anti-tumour effects of temozolomide on colorectal cancer. Journal of Chemotherapy 2022; 34(6): 391 doi: 10.1080/1120009X.2021.2009987
|
| 23 |
Anna S. Berghoff, Matthias Preusser. New developments in brain metastases. Therapeutic Advances in Neurological Disorders 2018; 11: 175628641878550 doi: 10.1177/1756286418785502
|
| 24 |
Ameen A. Mohammed, Fabio Rotondo, David G. Munoz, Kalman Kovacs, Juan M. Bilbao, Jason R. Karamchandani, Antonio Di Ieva, Michael D. Cusimano. Diagnostic and prognostic biomarkers of a sellar melanocytic tumor mimicking pituitary adenoma: Case report and literature review. Pathology - Research and Practice 2015; 211(9): 682 doi: 10.1016/j.prp.2015.04.005
|
| 25 |
Sneha Rathi, Jessica I. Griffith, Wenjuan Zhang, Wenqiu Zhang, Ju‐Hee Oh, Surabhi Talele, Jann N. Sarkaria, William F. Elmquist. The influence of the blood–brain barrier in the treatment of brain tumours. Journal of Internal Medicine 2022; 292(1): 3 doi: 10.1111/joim.13440
|
| 26 |
Jac Dinnes, Rubeta N Matin, Jacqueline F Moreau, Lopa Patel, Sue Ann Chan, Naomi Chuchu, Susan E Bayliss, Matthew Grainge, Yemisi Takwoingi, Clare Davenport, Fiona M Walter, Colin Fleming, Julia Schofield, Neil Shroff, Kathie Godfrey, Colette O'Sullivan, Jonathan J Deeks, Hywel C Williams. Tests to assist in the diagnosis of cutaneous melanoma in adults: a generic protocol. Cochrane Database of Systematic Reviews 2015; doi: 10.1002/14651858.CD011902
|
| 27 |
Mohini Singh, David Bakhshinyan, Chitra Venugopal, Sheila K. Singh. Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System. Frontiers in Oncology 2017; 7 doi: 10.3389/fonc.2017.00220
|
| 28 |
R.A. Harris. Chemotherapy drug temozolomide adsorbed onto iron-oxide (Fe3O4) nanoparticles as nanocarrier: A simulation study. Journal of Molecular Liquids 2019; 288: 111084 doi: 10.1016/j.molliq.2019.111084
|
| 29 |
Raviteja Suryadevara, Hassen Fadel, Sharon K. Michelhaugh, Sandeep Mittal, Prahlad Parajuli. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors. 2018; : 1 doi: 10.1016/B978-0-12-812218-1.00001-4
|
| 30 |
Herbert B. Newton. Handbook of Neuro-Oncology Neuroimaging. 2016; : 23 doi: 10.1016/B978-0-12-800945-1.00003-3
|
| 31 |
Laura Marconato, Carla Rohrer Bley, Vito F. Leone, Riccardo Finotello. An open‐label dose escalation study evaluating tolerability and safety of a single 5‐days course of temozolomide in dogs with advanced cancer. Veterinary and Comparative Oncology 2020; 18(4): 838 doi: 10.1111/vco.12623
|
| 32 |
Brain Metastases: State of the Art and Innovative Targeted Therapies. Journal of Analytical Oncology 2015; 4(3) doi: 10.6000/1927-7229.2015.04.03.4
|
| 33 |
Gui-Rong Bai, Jin-Bing An, Yang Chu, Xiang-Yang Wang, Shu-Ming Li, Kai-Jing Yan, Fu-Rong Lü, Ning Gu, Amanda N. Griffin, Bin-Yuan Sun, Wei Li, Guo-Cheng Wang, Shui-Ping Zhou, He Sun, Chang-Xiao Liu. Comparison of the effectiveness of whole-brain radiotherapy plus temozolomide versus whole-brain radiotherapy in treating brain metastases based on a systematic review of randomized controlled trials. Anti-Cancer Drugs 2016; 27(1): 1 doi: 10.1097/CAD.0000000000000295
|
| 34 |
Pitchaya Wanleenuwat, Piotr Iwanowski. Metastases to the central nervous system: Molecular basis and clinical considerations. Journal of the Neurological Sciences 2020; 412: 116755 doi: 10.1016/j.jns.2020.116755
|
| 35 |
Thomas Chen, Clovis Da Fonseca, Axel Schönthal. Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases. International Journal of Molecular Sciences 2016; 17(9): 1463 doi: 10.3390/ijms17091463
|
| 36 |
Herbert B. Newton. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. 2018; : 527 doi: 10.1016/B978-0-12-812100-9.00042-5
|
| 37 |
Nicolly Espindola Gelsleichter, Priscila Oliveira de Souza, Fernanda Cardoso Teixeira, Gabriela Nogueira Debom, Gabriela Spies Lenz, Gabriela Gonçalves Roliano, Rita de Cássia Sant’ana, Fernanda Visioli, Flávia Nathiely Silveira Fachel, Luana Roberta Michels, Juliana Hofstätter Azambuja, Helder Ferreira Teixeira, Elizandra Braganhol. Metastatic Melanoma: A Preclinical Model Standardization and Development of a Chitosan-Coated Nanoemulsion Containing Temozolomide to Treat Brain Metastasis. Cellular and Molecular Neurobiology 2023; 43(6): 2939 doi: 10.1007/s10571-023-01338-4
|
| 38 |
Jacob Zaemes, Ali Alzeer, Kathryn Villa, Michael Atkins. A Patient with Melanoma that Became Sensitized to Immunotherapy After Treatment with a CDK4/6 Inhibitor. Immunotherapy 2020; 12(12): 861 doi: 10.2217/imt-2020-0139
|
| 39 |
Itamar Luís Gonçalves, Liliana Rockenbach, Gustavo Machado das Neves, Gabriela Göethel, Fabiana Nascimento, Luciano Porto Kagami, Fabrício Figueiró, Gabriel Oliveira de Azambuja, Amanda de Fraga Dias, Andressa Amaro, Lauro Mera de Souza, Ivan da Rocha Pitta, Daiana Silva Avila, Daniel Fábio Kawano, Solange Cristina Garcia, Ana Maria Oliveira Battastini, Vera Lucia Eifler-Lima. Effect of N-1 arylation of monastrol on kinesin Eg5 inhibition in glioma cell lines. MedChemComm 2018; 9(6): 995 doi: 10.1039/C8MD00095F
|
| 40 |
Herbert B. Newton, Seema Shroff, Mark G. Malkin. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. 2022; : 79 doi: 10.1016/B978-0-12-821976-8.00013-X
|
| 41 |
Carlos Kamiya-Matsuoka, David Cachia, Steven G. Waguespack, Christopher H. Crane, Anita Mahajan, Paul D. Brown, Joo Yeon Nam, Ian E. McCutcheon, Marta Penas-Prado. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary 2016; 19(4): 415 doi: 10.1007/s11102-016-0721-6
|
| 42 |
Adam Lauko, Yasmeen Rauf, Manmeet S Ahluwalia. Medical management of brain metastases. Neuro-Oncology Advances 2020; 2(1) doi: 10.1093/noajnl/vdaa015
|
| 43 |
Michiko N. Fukuda, Misa Suzuki-Anekoji, Motohiro Nonaka. Central Nervous System Tumors. 2022; doi: 10.5772/intechopen.96517
|
| 44 |
Albert E. Kim, Edwin Nieblas-Bedolla, Magali A. de Sauvage, Priscilla K. Brastianos. Leveraging translational insights toward precision medicine approaches for brain metastases. Nature Cancer 2023; 4(7): 955 doi: 10.1038/s43018-023-00585-0
|